Skip to main content

Table 1 Baseline clinical patient characteristics

From: Blood circulating bacterial DNA in hospitalized old COVID-19 patients

 

Discharged n = 102

Deceased n = 47

p-value

Age, mean ± SEM

84.00 ± 0.65

89.20 ± 0.97

 < 0.001

Male sex, n (%)

38 (37.3%)

18 (38.3%)

0.907

Hypertension, n (%)

73 (73.0%)

34 (73.9%)

0.908

Diabetes, n (%)

27 (27.0%)

9 (19.6%)

0.333

COPD, n (%)

11 (11.0%)

11 (23.9%)

0.043

IHD, n (%)

11 (11.0%)

8 (17.4%)

0.286

AF, n (%)

26 (26.0%)

17 (37.0%)

0.177

Dementia, n (%)

31 (31.0%)

14 (30.4%)

0.945

CKD, n (%)

22 (21.5%)

17 (36.2%)

0.072

Respiratory insufficiency, n (%)

64 (62.7%)

43 (91.4%)

 < 0.001

Fever, n (%)

48 (47.0%)

24 (51.5%)

0.725

Cough, n (%)

31 (30.4%)

6 (12.7%)

0.020

CFS n (%)

0–3

20 (19.6%)

(4.3%)

0.035

4–7

51 (50.0%)

24 (51.1%)

8–9

29 (28.4%)

21 (44.7%)

na

2 (2.0%)

0 (0.0%)

CRP (mg/L), mean ± SEMa

5.15 ± 0.73

9.32 ± 1.05

 < 0.001

Lymphocytes (103/µL), mean ± SEMa

1.41 ± 0.10

1.03 ± 0.15

0.004

Neutrophils (103/µL), mean ± SEMa

5.38 ± 0.47

8.73 ± 0.68

 < 0.001

NLR, mean ± SEMa

4.87 ± 1.09

13.60 ± 1.56

 < 0.001

Fibrinogen (mg/dL), mean ± SEMa

433 ± 17

460 ± 27

0.275

D-dimer (ng/mL), mean ± SEMa

1782 ± 371

2725 ± 601

0.130

Procalcitonin (ng/mL), mean ± SEMa

0.13 ± 0.35

2.29 ± 0.61

0.001

BB-DNA (ng/mL), mean ± SEMa

19.0 ± 8.7

49.7 ± 11.4

0.015

  1. Chronic Obstructive Pulmonary Disease (COPD), Ischemic Heart Disease (IHD), Atrial Fibrillation (AF), Chronic Kidney Disease (CKD), C-Reactive Protein (CRP), Clinical Frailty Scale (CFS), Neutrophil to lymphocyte ratio (NLR), Not available (na), Standard Error of the Mean (SEM)
  2. aANCOVA analysis correcting for age, sex, and corticosteroid therapy